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Adrenergic control of cAMP generation in rat inner medullary collect-
ing tubule cells. The adrenergic nervous system profoundly alters water
excretion by both renal and extrarenal pathways. The effects of
catecholamines on cultured rat inner medullary collecting tubule cells
were studied. The /3-adrenergic agonist, isoproterenol, increases cAMP
from 19.5 2.3 to 79.4 14.4 fm/tg protein, P < 0.001 The response
to arginine vasopressin (AVP) is also greater in the presence of
isoproterenol, but the increment is unchanged when compared to that
seen in the absence of AVP. The agonist effect of isoproterenol is
blocked by propranolol but not by the specific f3 antagonist, atenolol.
The effect of a-adrenergic stimulation was studied by the use of
norepinephrine (NE) in the background of the /3 blocker, propranolol.
NE decreases AVP-stimulated cAMP generation from 190 11 to 117
10 fmItg, P < 0.001, N 6. The specific a2 antagonist, yohimbine,
but not the a1 antagonist, prazosin, prevents the NE-induced decrease
as AVP-stimulated cAMP is restored to 187 19 fm/sg. Similarly the
selective a2 agonist, clonidine, significantly inhibits both AVP- and
isoproterenol-mediated cAMP generation. To define the site of a2
inhibition in the adenylate cyclase (AC) complex the effect of pertussis
toxin (PT) was investigated. After pretreatment with PT (1-1000 ng/ml),
AVP-stimulated cAMP was not inhibited by NE. The a1 agonist,
phenylephrine, fails to inhibit AC or to increase cytosolic Ca in these
cells. We conclude that /3-adrenergic stimulation increases basal cAMP
generation but has no further effect on AVP-stimulated levels, a-
adrenergic stimulation impairs AVP-stimulated cAMP generation (this
effect is due to occupancy of the a2 receptor), and the effect is mediated
by a PT-inhibitable protein.
The recognition that the sympathetic nervous system plays
an important role in the control of water excretion dates back to
the observations of Verney [1]. Subsequent in vivo studies
defined an effect of /3-adrenergic agonists to cause antidiuresis
by stimulating arginine vasopressin (AVP) release [2], whereas
a-adrenergic agonists cause a water diuresis primarily by inhib-
iting release of the hormone [31. Both of these effects were
mediated by alterations in baroreceptor tone [4, 5]. While these
in vivo studies pointed to an important central effect of cate-
cholamines to modulate water excretion they provide no sup-
port for an intrarenal mechanism. This is compatible with the
failure to observe an effect of catecholamines on the hydroos-
motic response to AVP in isolated rat papillae [61. In contrast,
observations in the toad urinary bladder [7] and more recently
in perfused rabbit cortical collecting tubules [8, 9] strongly
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suggest an inhibitory effect of a2-adrenergic stimulation on the
hydroosmotic response to AVP, while f3-adrenergic stimulation
is without effect [8]. The biochemical correlates of these phys-
iologic studies have yielded somewhat conflicting results. As
regards /3-adrenergic stimulation, isoproterenol does not affect
cAMP accumulation in either rat renal medullary [10] or papil-
lary tubules [6]. On the other hand, Charbardes et al were able
to demonstrate isoproterenol-stimulated adenylate cyclase
(AC) activity in cortical and, to a lesser degree, medullary
collecting tubules of the rabbit [11] and in cortical collecting
tubules of the rat [12]. Data regarding the effects of a-adrenergic
stimulation are similarly conflicting. Thus, while one study
failed to demonstrate an effect of a-adrenergic agents on
AVP-stimulated AC activity in the rat inner medullary collect-
ing tubule (RIMCT) [13], other studies do demonstrate a-
adrenergic antagonism of AVP action in the rat renal medulla
[10, 12, 14, 15]. In none of these studies, however, is the
mechanism of inhibition by a-adrenergic agonists defined. The
present studies were undertaken to reconcile the previously
reported discrepancies and to define the mechanism of inhibi-
tion by examining adrenergic modulation of cAMP formation in
a homogeneous population of cultured RIMCT cells.
Methods
RJMCT cell culture
Tissue was prepared from male Sprague-Dawley rats by a
modification of the method of Grenier, Rollins and Smith [16] as
previously reported from this laboratory [17]. The morphologic
and biochemical characteristics of these cultured cells have
been previously described [16, 17]. Experiments were per-
formed at 72 to 96 hours in a nonconfluent state when each well
contained 30 to 60 tg of protein.
Incubation with effector solutions for determination of cAMP
generation
All studies were performed in a Krebs-Ringer buffer 300
mOsm/kg H,O, at 37°C, and in the presence of 0.5 mtvi IBMX as
described previously [17]. Intracellular cAMP was determined
by radioimmunoassay and cellular protein by the method of
Lowry et al [18] as previously described. In studies utilizing a
or /3 antagonists, cells were pretreated with the antagonist for
five minutes prior to exposure to AVP. Selectivity ratios for the
adrenergic agents employed in this study are presented in Table
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Table 1. Selectivity ratios of adrenergic agents employed in this
study
u-Adrenergic agents
Agonist a1:a2 Selectivity
Norepinephrine 2:1
Phenylephrine 50: I
Clonidine I : 10
Antagonist
Prazosin >100:1
Yohimbine 1:80
/3drenergic agents
Agonist f3:j3, Selectivity
Isoproterenol 1:
Antagonist
Propranolol I:
Atenolol 20:1
Measurement of cytosolic Ca
Tissue was prepared as described above but grown on 13 mm
diameter glass coverslips for seven days prior to study. Cells
were fed on days 1, 2 and 6. On day 7, cultures were washed
twice with physiological saline solution (PSS; composition in
mM: 140 NaCI, 4.6 KCI, 2.5 CaCI2, 1.0 MgCl2, 10 glucose, 10
hepes), pH 7.4. The monolayers were then loaded with fura 2
AM (4 /LM) for 60 minutes in PSS, 37°C. The cultures were then
washed with PSS twice more, to remove excess unhydrolyzed
fura 2 AM, and transferred to a duvette. Measurements of
fluorescence before and after exposure to l0 M phenylephrine
were obtained at excitation wavelengths of 340 and 380 nm on
a Perkin-Elmer 650-lOS fluorescence spectrophotometer. Emis-
sion was read at 500 nm. After correction for autofluorescence
the cytosolic Ca2 concentration was calculated from the
equation:
[Ca2'i = Kd (R — Rrnin/Rmax — R) (Sf,/Sb2)
t1''"
I
as described previously [17].
Histochemical staining
Tissue was prepared as described and plated onto 13 mm
diameter glass coverslips. Histochemical staining for succinic
dehydrogenase was performed on day 3 as described by
Nachlas et al [221.
Statistical analysis
Comparison between any two experimental settings was done
with the unpaired Student's i-test. When comparisons involved
multiple groups, an analysis of variance was performed 123]. All
data are expressed as mean SE. A P value of <0.05 was
considered significant. In all instances, "N" refers to the
number of separate primary cultures studied, each of which is
itself the mean of three separate measurements of cAMP
accumulation.
Results
Studies on the f3-adrenergic system
Preliminary studies of the dose-response to isoproterenol
(Elkins-Sinn, Inc., Cherry Hill, New Jersey, USA) in RIMCT
cells revealed significant stimulation of cAMP formation at a
concentration of isoproterenol as low as iø— M. Maximum
stimulation was achieved at l0— increasing the concentra-
tion to iø— M decreased cAMP formation. In all studies of
/3-adrenergic stimulation in RIMCT cells, isoproterenol was
employed at l0 M.
Effect of f3-adrenergic stimulation on cAMP formation in the
presence and absence of AVP
Exposure of RIMCT cells to l0— M isoproterenol increased
cAMP formation from 19.5 2.3 to 79.4 14.4 fmol/sg protein
(P < 0.001, Fig. 1). A potential interaction of this adrenergic
agonist with the well recognized effect of AVP was assessed by
studying the response to AVP in the absence and presence of
isoproterenol. As depicted in Figure 1, at all concentrations of
AVP studied, cAMP generation was greater in the presence of
isoproterenol. However, at no concentration was this incre-
ment significantly different from that achieved by isoproterenol
in the absence of AVP.
Effect of /3-adrenergic antagonists on
isoproterenol-stimulated cAMP formation
To determine whether isoproterenol-stimulated cAMP gener-
ation is mediated by the /3 or /32 receptor, propranolol (a
non-selective /3 blocker; Ayerst Labs, Inc., New York, New
York, USA) and atenolol (a selective /3 blocker; Sigma Chem-
Data adapted from references 19—21.
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Fig. 1. Dose-response curves to A VP in the absence (closed circles) or
presence (open circles) of isoprozerenol (ISO, IO M, N = 6). cAMP
accumulation is consistently elevated in the presence of isoproterenol.
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Fig. 2. Effects of propranolol (PR, IO— M) and atenolol (AT, IO M)
on isoproterenol (ISO, iO M) stimulated cAMP generation (N = 4).
PR completely prevents the ISO-induced increase in cAMP while AT is
without effect.
ical Co., St. Louis, Missouri, USA) were employed. As de-
picted in Figure 2, pretreatment of RIMCT cells with propran-
olol (l0 M) completely blocked the isoproterenol effect. In
contrast, pretreatment with atenolol had no such inhibitory
property, indicating that the isoproterenol effect is mediated by
occupancy of the f2 receptor.
Characterization of cells by staining for succinic
dehydrogenase (SDH)
To determine whether the isoproterenol-stimulated AC activ-
ity we detected resided in principal cells or intercalated cells,
we undertook histochemical studies. Because of their abundant
mitochondria intercalated cells exhibit strong staining for SDH;
in contrast, the relatively mitochondria-poor principal cells
stain little, if at all [24]. Despite positively staining controls,
RIMCT cells were negative for SDH staining. Only 1 in
approximately 2500 cells exhibited evidence of SDH activity.
These results indicate that both AVP and isoproterenol stimu-
late cAMP formation in principal cells.
Studies on the a-adrenergic system
a-Adrenergic stimulation was achieved with the endogenous
catecholamine, norepinephrine (NE; Winthrop-Breon Labs.,
Inc., New York, New York, USA). In order to inhibit any
/3-adrenergic agonist effect of NE, experiments were conducted
in the background of l0 Mpropranolol. In preliminary studies
(Fig. 3), we demonstrated an effect of NE to significantly inhibit
AVP-stimulated cAMP production at a concentration of NE as
low as lO M (P < 0.05). Increasing NE to iO M resulted in
a further significant decrease (P < 0.02) in AVP-stimulated
cAMP production. Therefore, in all studies of a-adrenergic
stimulation in RIMCT cells, agonists were employed at io— M.
Effect of a-adrenergic agonists on A VP-stimulated cAMP
generation
Dose-response curves to AVP were obtained in the absence
and presence of 1O M NE. As seen in Figure 4, NE had no
effect on basal cAMP production; however, at all concentra-
tions of AVP employed significant NE-induced inhibition was
observed (P < 0.001). Since NE has both a and a2 agonistic
properties, the response to AVP was studied with the highly
selective a1 agonist, phenylephrine (Sigma), and the a2 agonist,
clonidine (Sigma). As depicted in Figure 5, the inhibitory action
of a-adrenergic stimulation observed with NE was mimicked by
clonidine. Similarly, clonidine inhibits isoproterenol-stimulated
cAMP generation from 148.23 11.18 to 110.24 11.21 fmol/
sg protein (N = 6, P < 0.05; data not shown). In contrast,
phenylephrine did not alter the response to AVP, suggesting
that the effect of NE was mediated by the a2 receptor.
Effect ofa-adrenergic antagonists on the inhibition by NEPR
To further define the nature of a-adrenergic inhibition of
AVP-stimulated cAMP formation, selective a1 and a2 antago-
nists were employed (Table 1). As noted in Figure 6, NE caused
a decrease in cAMP formation from 186.6 12.5 to 104.7
10.6 (P < 0.005) in agreement with data shown above. The
highly specific a1 antagonist, prazosin (Sigma), did not alter the
response to AVP and, more importantly, had no effect on
NE-induced inhibition as the agonist still significantly de-
creased cAMP formation from 188,1 28.3 to 108.8 11.0 (P
<0.05). Experiments performed with the a2 antagonist, yohim-
bine (Sigma), yielded different results. While yohimbine itself
had no effect on AVP-stimulated cAMP generation, it com-
pletely reversed the inhibitory effect of NE. AVP-stimulated
cAMP formation in the presence of NE after pretreatment with
yohimbine was indistinguishable from that generated by AVP
alone. These experiments add further credence to the conten-
tion that it is the a2 rather than the a receptor that exerts an
inhibitory effect on the response to AVP.
Mechanism of a2-mediated inhibition of A VP-stimulated
cAMP generation
a2-Adrenergic agents are generally felt to exert their effects
via the inhibitory guanine nucleotide binding regulatory protein
G, (N1). To determine if this same mechanism is operant in the
RIMCT, we examined the effect of NEPR on cells pretreated
with pertussis toxin (1-1000 ng/ml for 16 hr; List Biological,
Campbell, California, USA). Pertussis toxin ADP-ribosylates
the a subunit of G, thereby eliminating its inhibitory effects [25].
As depicted in Figure 7, pertussis toxin (1 gJml) alone had a
small but statistically insignificant effect to enhance AVP-
stimulated cAMP generation. Yet, a 16 hour incubation with
pertussis toxin at concentrations ranging from 1000 to as little as
I ng/ml completely prevented NE inhibition of AVP-stimulated
cAMP formation. We have previously demonstrated that treat-
ment of RIMCT cells with pertussis toxin prevents subsequent
ADP-ribosylation of a 41 kDa protein in plasma membranes
prepared from the treated cells [26]. These results indicate that
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Fig. 3. Effect of vatying concentrations of
norepinephrine (NE, N = 4) on iO MA VP—
stimulated cAMP accumulation. Inhibition is
observed at concentrations of NE  lO si.
a2-adrenergic inhibition of cAMP formation is mediated by the
inhibitory guanine nucleotide-binding protein, G1.
Effect of a1-adrenergic stimulation on cell Ca in RIMCT cells
Since a1-adrenergic stimulation in various tissues is linked to
phospholipase C-stimulated phosphatidylinositol hydrolysis
leading to an increase in cellular Ca [27—29], we investigated
whether phenylephrine increases cell Ca in RIMCT. In five
observations, cellular Ca failed to increase in response to the a1
agonist as mean intracellular Ca was 193.3 47.4 flM before and
175.7 23.9 n after a five minute exposure to 10 M
phenylephnne. In contrast, the non-fluorescent calcium lono-
phore [30], bromo A23 187 (HSC Research Development Corp.,
Toronto, Canada; 2 tM), caused a pronounced increase in Ca2
to >2 M.
Discussion
The experiments described herein define the biochemical
effects of adrenergic agents on the terminal portion of the
RIMCT. The identities of the adrenergic receptors involved in
the responses are elucidated and the interactions of adrenergic
agents with AVP are defined. Our initial experiments were
directed at clarifying the effects of f3-adrenergic stimulation on
cAMP formation. It is evident that the /3 agonist, isoproterenol,
increases cAMP formation in a dose-dependent fashion. In this
regard, our results are in line with those of Chabardes et a! [12]
who describe a modest agonist effect of isoproterenol in cortical
collecting tubules of the rat, but are not compatible with the
negative results obtained by Kurokawa and Massry [10] and
Rayson, Ray and Morgan [6]. In addition, we also studied the
interaction of isoproterenol with AVP. Our results employing
maximal concentrations of these agents reveal that the effect of
isoproterenol is additive to that of AVP. Thus, the increment in
cAMP accumulation caused by isoproterenol (I0— M) in the
presence of AVP (10—v M) was not significantly different from
that seen in the absence of AVP. This lack of interaction
suggests independent sites of action and, most likely, of dif-
ferent adenylate cyclases. Experiments performed with /3-
adrenergic antagonists reveal that it is the /32 rather than the /3
receptor that is responsible for this effect. Previous studies [11,
12] did not identify the type of /3 receptor involved in the
stimulation of cAMP formation.
It is by now well established that collecting tubule epithelium
consists of two cell types, principal cells and intercalated cells
[24]. While the principal cell appears to serve as the target for
AVP action, the intercalated cell has been proposed as a
possible target for the action of isoproterenol. The rabbit
cortical collecting tubule exhibits no hydroosmotic response to
isoproterenol [8]. K secretion in this nephron segment is
inhibited by isoproterenol via a process believed to be cAMP
mediated [31]. Therefore, despite the uniform morphologic
appearance of our cultured cell system [16, 17], these findings
raised the possibility that we, in fact, have a heterogeneous
population of both principal and intercalated cells.
To assess the homogeneity of our cultures, we stained for
succinic dehydrogenase, a mitochondrial enzyme that is abun-
dant in intercalated cells but not in principal cells [24]. We
found fewer than 1 in 2000 cells to exhibit staining for SDH
similar to the previously reported observations of Kleinman et
at in the same cell system [321. These findings indicate that the
principal cell of the RTMCT exhibits both AVP- and isoproter-
enol-stimulated cAMP formation. The possibility that yet an-
other cell that does not stain for SDH is responsible for the
effect was not evaluated. The physiologic significance of the
/3-adrenergic response is unclear as neither in vivo intrarenal
infusion of isoproterenol [21 nor in vitro perfusion of cortical
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collecting tubules [9] with the agent causes antidiuresis. It could
be surmised that the cAMP generated by /3-adrenergic stimula-
tion either undergoes subcellular compartmentalization or that
it activates protein kinases other than those involved in the
process of water transport.
The experiments conducted with a-adrenergic agonists and
antagonists indicate the existence of an a-adrenergic receptor
that inhibits the response to both AVP and isoproterenol.
Inhibition is observed in response to a pharmacologic agent
such as clonidine and in response to the endogenous catechol-
amine, NE, at a concentration as low as iO M. The observa-
tion that suppression by clonidine, though still significant, is
somewhat less marked than that caused by NE, is entirely
consistent with the previously recognized property of clonidine
being only a partial adrenergic agonist [33].
a-Adrenergic inhibition is mediated by the a2 rather than the
a1 receptor, as antagonism of the former but not the latter
prevents the inhibitory action of a agonists. These results do
not support the early observations of Morel, Imbert-Teboul and
Charbardes [13], who failed to see antagonism of AVP-stimu-
lated AC activity by a-adrenergic agents. However, the results
are in concert with later experiments from that group [12] and
provide the biochemical mechanism responsible for the a-
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Fig. 4. Dose-response curves to AVP in the absence (closed circles) or
presence (open circles) of norepinephrine + propranolo! (NEPR, lO
M each, N = 6). NEPR significantly (P < 0.001) inhibits AVP-
stimulated cAMP generation at each concentration of AVP.
I I
AVP AVP AVP AVP
+ +
PHE CL
108 io-
150
100
0
50
0•
(N=6) (N=5)
Fig. 5. Effects of phenylephrine (Phe, io— M) and clonidine (Cl, iO
M) on A VP-stimulated cAMP generation. Cl, but not Phe, mimics the
inhibitory effect of norepinephrine.
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Fig. 6. Effects of prazosin (PZ, 1O M) andyohimbine (I', 1O M) on
A VP-stimulated cAMP generation and its inhibition by norepinephrine
(N = 6). Neither PZ (3rd column) nor Y (5th column) itself alters cAMP
generation; Y (6th column), but not PZ (4th column), prevents inhibi-
tion by NEPR.
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adrenergic antagonism of AVP-stimulated water flow in per-
fused rabbit cortical collecting tubules [8,9]. While those stud-
ies [8, 9, 12] suggested a pre-cAMP site of action, they were not
accompanied by concomitant biochemical measurements. The
pre-cAMP mechanism whereby a2 agonists operate is further
substantiated by a recent physiologic study employing pertussis
toxin [34], as well as the data presented herein. Pertussis toxin
ADP-ribosylates the a subunit of the inhibitory guanine nude-
otide regulatory protein, G1, thereby inactivating it. As such it
has become a useful tool to explore the role of this protein in
cellular functions. Our studies demonstrate that a2-adrenergic-
mediated antagonism of AVP stimulation is prevented in cells
pretreated with pertussis toxin for 16 hours. We have noted that
in intact cells a much shorter pretreatment (3 hr) provides only
a partial ribosylation of G1. Unlike Ribeiro et al [34] who found
a protective effect of pertussis toxin only at concentrations of
500 ng/mI or higher, we have demonstrated prevention of
a2-adrenergic-mediated inhibition of cAMP accumulation with
as little as 1 nglml of pertussis toxin. Importantly, pertussis
toxin itself causes no significant alteration in cAMP formation.
The data, therefore, strongly supports the contention that the
inhibitory effects observed with clonidine and NE are mediated
by the guanine nucleotide inhibitory protein, G.
The experiments conducted with a1 agonists and antagonists
failed to show any discernable effects on cAMP formation.
Since a1-adrenergic agonists have been found to stimulate
phosphatidylinositol hydrolysis in other tissues thereby increas-
ing cytosolic Ca, we explored whether such an effect is evident
in inner medullary collecting tubule cells. In multiple determi-
nations, concentrations of phenylephrine as high as 10 M
failed to produce a discernable change in the Ca signal, which is
clearly discernable under identical experimental circumstances
I Fig. 7. Effect of pertussis toxin (PT, 1-1000J I ng/mI) on A VP-stimulated cAMP generationI and its inhibition by norepinephrine (N = 4).L ______ PT has no significant effect on AVP-
stimulated cAMP generation but, at all+ + concentrations employed, completely
100 10 1 prevents inhibition by NEPR.
with bromo A23 187. This suggests that, unlike the situation in
the rabbit cortical collecting tubule [8], a1 -adrenergic agonists
are devoid of biochemical actions in the terminal collecting
tubule of the rat.
In summary, the results of these experiments allow us to
conclude that /32- but not /31-adrenergic stimulation increases
both basal and AVP-stimulated cAMP generation in an additive
but not synergistic fashion. While a1 stimulation has no bio-
chemical effects, a2 stimulation inhibits both isoproterenol- and
AVP-stimulated cAMP generation. This a2 receptor occu-
pancy, transduced via the inhibitory guanine nucleotide regu-
latory protein G1, is most likely intimately involved in attenu-
ating the cellular response to AVP resulting in decreased water
reabsorption.
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